Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Trichlorethanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trichlorethanol SCHEMBL2141590 | 0.97 | FFAR3 (0.47) | FFAR3LCKFYNALDH1A1TSHR | |
| Trichlorethanol SCHEMBL11032894 | 0.80 | PAOX (0.32) | ALDH1A1TDP1OR51E2 | |
| Trichlorethanol SCHEMBL28825711 | 0.80 | TSHR (0.41) | ALDH1A1TSHRTP53OR51E2 | |
| Trichlorethanol SCHEMBL1065673 | 0.79 | — | — | |
| Acetic Acid SCHEMBL4980947 | 0.78 | FFAR3 (0.47) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL10866598 | 0.78 | FFAR3 (0.47) | FFAR3LCKFYNALDH1A1TSHR | |
| Acetic Acid SCHEMBL11104309 | 0.77 | FFAR3 (0.39) | FFAR3LCKFYNALDH1A1TSHR | |
| Trichlorethanol SCHEMBL7654054 | 0.75 | — | — | |
| Carbon Tetrachloride SCHEMBL3963583 | 0.75 | — | — | |
| Acetic Acid SCHEMBL28252030 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130302247-A1 | SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2013-11-14 | — | — | US | disclosed |
| EP-0407390-B1 | BIOCOMPATIBLE COATINGS | BSI CORP (US) | 1996-04-24 | — | — | EP | disclosed |
| EP-0407390-A4 | BIOCOMPATIBLE COATINGS | — | 1991-12-11 | — | — | EP | disclosed |
| EP-0407390-A1 | BIOCOMPATIBLE COATINGS. | BIO METRIC SYSTEMS INC (US) | 1991-01-16 | — | — | EP | disclosed |
| WO-1989005616-A1 | BIOCOMPATIBLE COATINGS | BIO-METRIC SYSTEMS, INC. (US) | 1989-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130302247-A1 | SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF | ALOX15B, ALOX15, ALOX5 | FFAR3 81/4885LCK 3429/4885FYN 780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.